PMC:7200337 / 101220-101319
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T14 | 88-90 | http://purl.obolibrary.org/obo/PR_000005794 | denotes | CP |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T13081 | 88-90 | Chemical | denotes | CP | http://purl.obolibrary.org/obo/CHEBI_3380|http://purl.obolibrary.org/obo/CHEBI_73461 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3412 | 88-90 | Gene | denotes | CP | Gene:1356 |
| 3420 | 37-39 | Gene | denotes | to | Gene:6999 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T592 | 0-99 | Sentence | denotes | Further controlled trials are needed to determine the optimal timing and indication for CP therapy. |